PMV Pharmaceuticals Inc reports results for the quarter ended in September - Earnings Summary

Pmv Pharmaceuticals

10/11/2022 13:16

* PMV Pharmaceuticals Inc  PMVP.OQ  reported a quarterly
adjusted
loss of 40 cents​​ per share for the quarter ended in September.
The mean expectation of six analysts for the quarter was for a
loss of 42 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * PMV Pharmaceuticals Inc's reported EPS for the quarter was
a
loss of 40 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * PMV Pharmaceuticals Inc shares had fallen by 17.8% this
quarter and lost 57.7% so far this year.
    * The company reported a quarterly loss of $18.23 million.
    * Wall Street's median 12-month price target for PMV
Pharmaceuticals Inc is $39.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
10 at 01:16 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.42          -0.40          Beat
 Jun. 30 2022      -0.41          -0.38          Beat
 Mar. 31 2022      -0.40          -0.41          Missed
 Dec. 31 2021      -0.35          -0.40          Missed